Zacks.com on MSN
Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics
Wall Street analysts expect Illumina (ILMN) to post quarterly earnings of $1.05 per share in its upcoming report, which indicates a year-over-year increase of 8.3%. Revenues are expected to be $1.08 ...
This World Immunisation Week and beyond, MSF teams share access and innovation advancements that, if achieved in the years to ...
How SARS-CoV-2 impacts astrocyte function in neurocovid-19 and what this means for brain health, neurological symptoms, and ...
Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based ...
13don MSN
Biological shield can prevent skin cancer cells from transforming into aggressive metastatic forms
A new study has identified a molecular guardian that keeps skin cells from forgetting what they are and transforming into ...
Morning Overview on MSN
Long-read RNA sequencing tool boosts rare-disease diagnoses missed by DNA tests
For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for ...
Morning Overview on MSN
Nanotweezers capture thousands of cell vesicles fast to reveal cargo
A fingernail-sized chip can now trap thousands of individual cell-shed vesicles in roughly three seconds and read their molecular contents without dyes or labels. “We wanted a single device that could ...
Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss after bariatric surgery ...
Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss ...
Kathleen Elison is the co-founder and principal scientist at Terray Therapeutics, where she leads the research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results